Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Advances in Dermatology and Allergy Management
This week's episode covers groundbreaking research in dermatology and allergy management, including new ARIA guidelines for allergic rhinitis, advances in cosmetic dermatology with Profhilo®, and innovative treatments for conditions like prurigo nodularis and alopecia areata.
Bibliography
1. Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.
Authors: Sousa-Pinto B, Bousquet J, Vieira RJ, et al.
Journal: Allergy, 2026 Apr
PMID: 41324154
DOI: 10.1111/all.70131
2. A Systematic Review of the Efficacy and Safety of Profhilo® and Profhilo® Body.
Authors: Sparavigna A, Cigni C, Tanzini L, et al.
Journal: Plastic and aesthetic nursing, 2026 Apr-Jun 01
PMID: 41920062
DOI: 10.1097/PSN.0000000000000637
3. Exposome involvement in the development of acne vulgaris.
Authors: Grafanaki K, Bakoli Sgourou D, Maniatis A, et al.
Journal: Frontiers in immunology, 2026
PMID: 41924258
DOI: 10.3389/fimmu.2026.1779036
4. Efficacy and Safety of Conventional and Biologic Therapies in Prurigo Nodularis: A Systematic Review and Meta-Analysis.
Authors: Lancz A, Meznerics FA, Árok R, et al.
Journal: International journal of dermatology, 2026 Apr
PMID: 41495913
DOI: 10.1111/ijd.70246
5. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial.
Authors: Tsianakas A, Passeron T, Magnolo N, et al.
Journal: Journal of the American Academy of Dermatology, 2026 Apr
PMID: 41317911
DOI: 10.1016/j.jaad.2025.11.070
6. Update on occupational contact urticaria: a systematic narrative review.
Authors: Bizjak-Suran M, Jørgensen IL, Alfonso JH
Journal: Current opinion in allergy and clinical immunology, 2026 Apr 1
PMID: 41410133
DOI: 10.1097/ACI.0000000000001138
7. Alopecia areata.
Authors: Pratt CH, King LE Jr, Messenger AG, et al.
Journal: Nature reviews. Disease primers, 2017 Mar 16
PMID: 28300084
DOI: 10.1038/nrdp.2017.11
8. Cutaneous Manifestations of Inborn Errors of Immunity: Clinical Clues to Immune Disorders.
Authors: Napiorkowska-Baran K, Pastuszczak M, Płocka-Karpińska M, et al.
Journal: Medicina (Kaunas, Lithuania), 2026 Mar 19
PMID: 41901662
DOI: 10.3390/medicina62030581
9. Rosacea: New Concepts in Classification and Treatment.
Authors: van Zuuren EJ, Arents BWM, van der Linden MMD, et al.
Journal: American journal of clinical dermatology, 2021 Jul
PMID: 33759078
DOI: 10.1007/s40257-021-00595-7
10. SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in Germany.
Authors: Hilgefort L, Potthoff A, Nambiar S, et al.
Journal: Primary care diabetes, 2026 Apr
PMID: 41547635
DOI: 10.1016/j.pcd.2026.01.005
Authors: Sousa-Pinto B, Bousquet J, Vieira RJ, et al.
Journal: Allergy, 2026 Apr
PMID: 41324154
DOI: 10.1111/all.70131
2. A Systematic Review of the Efficacy and Safety of Profhilo® and Profhilo® Body.
Authors: Sparavigna A, Cigni C, Tanzini L, et al.
Journal: Plastic and aesthetic nursing, 2026 Apr-Jun 01
PMID: 41920062
DOI: 10.1097/PSN.0000000000000637
3. Exposome involvement in the development of acne vulgaris.
Authors: Grafanaki K, Bakoli Sgourou D, Maniatis A, et al.
Journal: Frontiers in immunology, 2026
PMID: 41924258
DOI: 10.3389/fimmu.2026.1779036
4. Efficacy and Safety of Conventional and Biologic Therapies in Prurigo Nodularis: A Systematic Review and Meta-Analysis.
Authors: Lancz A, Meznerics FA, Árok R, et al.
Journal: International journal of dermatology, 2026 Apr
PMID: 41495913
DOI: 10.1111/ijd.70246
5. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial.
Authors: Tsianakas A, Passeron T, Magnolo N, et al.
Journal: Journal of the American Academy of Dermatology, 2026 Apr
PMID: 41317911
DOI: 10.1016/j.jaad.2025.11.070
6. Update on occupational contact urticaria: a systematic narrative review.
Authors: Bizjak-Suran M, Jørgensen IL, Alfonso JH
Journal: Current opinion in allergy and clinical immunology, 2026 Apr 1
PMID: 41410133
DOI: 10.1097/ACI.0000000000001138
7. Alopecia areata.
Authors: Pratt CH, King LE Jr, Messenger AG, et al.
Journal: Nature reviews. Disease primers, 2017 Mar 16
PMID: 28300084
DOI: 10.1038/nrdp.2017.11
8. Cutaneous Manifestations of Inborn Errors of Immunity: Clinical Clues to Immune Disorders.
Authors: Napiorkowska-Baran K, Pastuszczak M, Płocka-Karpińska M, et al.
Journal: Medicina (Kaunas, Lithuania), 2026 Mar 19
PMID: 41901662
DOI: 10.3390/medicina62030581
9. Rosacea: New Concepts in Classification and Treatment.
Authors: van Zuuren EJ, Arents BWM, van der Linden MMD, et al.
Journal: American journal of clinical dermatology, 2021 Jul
PMID: 33759078
DOI: 10.1007/s40257-021-00595-7
10. SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in Germany.
Authors: Hilgefort L, Potthoff A, Nambiar S, et al.
Journal: Primary care diabetes, 2026 Apr
PMID: 41547635
DOI: 10.1016/j.pcd.2026.01.005
